Instructions for Vokara oral drops dropper bottle 20 ml
Composition
active ingredients: 100 ml of the preparation contains: Salvia D1 7 ml, Belladonna D6 10 ml, Phytolacca D6 10 ml, Lachesis D12 10 ml, Mercurius solubilis Hahnemanni D12 10 ml;
excipient: ethanol 43% (m/m).
1 ml of solution contains 25 drops.
Dosage form
Oral drops.
Main physicochemical properties: transparent, slightly yellowish liquid.
Pharmacotherapeutic group
A complex homeopathic remedy.
Pharmacological properties
The drug has a pronounced local and general anti-inflammatory effect.
In case of angina, scarlet fever, chronic tonsillitis, the drug's action is aimed at eliminating the symptoms of the disease. It prevents the chronicity of the inflammatory process and the occurrence of exacerbations.
Reduces hyperemia and edema of the palatine tonsils, accelerates the cleansing of the surface and lacunae from plaque and pus, reduces the risk of purulent-necrotic complications, and helps eliminate the focus of chronic intoxication.
Helps eliminate the manifestations of intoxication due to infection: elevated body temperature with chills, peripheral vascular spasm and impaired microcirculation, a feeling of weakness in the body, muscle pain, asthenia.
The immunomodulatory effect helps eliminate regional lymphadenopathy and lymphadenitis in diseases of the oropharynx and ENT organs.
Reduces manifestations accompanying scarlet fever, including immunopathological ones (lymphadenopathy, capillary toxicosis, myocarditis).
In pharyngitis, laryngitis, tracheitis, it reduces inflammation, persistent cough and sore throat, helps restore the structure and function of the mucous membrane. Reduces laryngospasm, facilitates breathing.
When treating stomatitis and gingivitis, it reduces redness and swelling of the mucous membrane, pain syndrome, and accelerates the healing of aphthae.
Indication
Treatment of inflammatory diseases of the oropharynx: tonsillitis (including Vincent-Plaut), chronic tonsillitis, pharyngitis, laryngitis, stomatitis, gingivitis, including those with regional lymphadenopathy and lymphadenitis.
Contraindication
Hypersensitivity to the active substances or to the excipients of the drug.
Interaction with other medicinal products and other types of interactions
There is currently no information regarding the drug's interactions with other medications.
An unhealthy lifestyle, the use of stimulants, and an unhealthy diet can negatively affect the effectiveness of homeopathic medicines.
Application features
Vokara® oral drops should not be used in patients with alcohol dependence, as one dose of the drug (5/10 drops) contains 80/160 mg of alcohol.
The alcohol content should also be taken into account when using the drug by pregnant women, breastfeeding women, children and patients at high risk of liver disease or epileptic seizures.
Vokara® oral drops contain traces of lactose monohydrate (less than 10 mg per maximum daily dose). This amount does not pose a risk for patients with lactose intolerance. Patients with rare hereditary forms of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
At the beginning of treatment with the drug, existing symptoms of the disease may temporarily worsen (primary reaction). This reaction is usually not harmful. If the symptoms do not disappear, the drug should be discontinued. After the disappearance of the primary reaction, the drug can be used again. If the symptoms worsen again, the drug should be discontinued.
If symptoms worsen, or if there is no improvement after 7 days of treatment, you should consult a doctor.
Long-term treatment with homeopathic medicines should be supervised by a doctor with experience in the use of homeopathic medicines, as symptoms not listed in the instructions for medical use may occur.
Since Vokara contains herbal and other natural ingredients, a slight change in the taste, transparency, or color of the solution may occur during storage, which does not lead to a decrease in the quality and effectiveness of the drug.
Use during pregnancy or breastfeeding
There are no data on the use of the drug during pregnancy and breastfeeding. There is no evidence of any risk of taking the drug during pregnancy and breastfeeding. The use of the drug during pregnancy or breastfeeding is recommended with caution.
There are no data on the effect of the drug on reproductive function.
The ability to influence the reaction speed when driving or working with other mechanisms
The drug has no or negligible influence on the ability to drive and use machines.
Method of administration and doses
Adults and children over 12 years of age: 10 drops of the drug in pure form or diluted in
1 tablespoon of water;
children 5-12 years old: 5-7 drops of the drug diluted in 1 tablespoon of water;
children 1-4 years old: 1-4 drops of the drug diluted in 1 tablespoon of water.
At the beginning of treatment, as well as in cases requiring rapid relief of symptoms, the drug can be taken every half hour to an hour up to 8 times a day until the condition improves, but not more than 3 days, after which it can be used 3 times a day.
To achieve maximum effect, it is recommended to take Vokara® between meals (30 minutes before or 1 hour after a meal). To enhance effectiveness, it is recommended to hold the drug in the mouth for some time before swallowing.
The course of treatment for acute diseases lasts until complete recovery. In the treatment of exacerbations of chronic diseases, the recommended course of treatment is 6 weeks.
In the treatment of chronic tonsillitis, an anti-relapse course of treatment is recommended - according to
6 weeks 2 times a year to prevent exacerbation of the disease.
Children
The medicine should be prescribed to children over 1 year of age.
The use of the drug in children under 1 year of age is not recommended due to insufficient data. Use the drug in children aged 1 to 6 years on the recommendation of a doctor.
Overdose
No cases of overdose have been registered.
Side effects
Allergic reactions, including rash, itching, urticaria, may occur. Increased salivation may occur after taking the drug. In this case, the use of the drug should be discontinued.
Expiration date
5 years.
Do not use the drug after the expiration date indicated on the package.
Storage conditions
Store the medicine in a tightly closed bottle in the original cardboard packaging at a temperature not exceeding 30 °C, out of the reach of children.
Packaging
20 ml or 50 ml or 100 ml in dark glass dropper bottles, in a cardboard box.
Vacation category
Without a prescription.
Producer
Richard Bittner AG.
Address
Ossiacherstrasse 7, A-9560 Feldkirchen, Austria.
